Prognostic factors in patients with oligometastatic breast cancer – A systematic review

Metastatic breast cancer (MBC) is traditionally regarded as an incurable condition and patients receive treatment with a palliative intent. A small subset of patients with MBC survives beyond 10  years and these patients often have limited metastatic burden, also referred to as oligometastases [1–4]. Hellman and Weichselbaum first introduced the term oligometastatic cancer to describe patients with limited metastatic burden in 1995 [5]. They postulated that oligometastatic cancer represe nts an intermediate state between localized disease and widespread metastatic cancer.

Source: Cancer Treatment Reviews - October 21, 2020 Category: Cancer & Oncology Authors: Annemiek van Ommen – Nijhof, Tessa G Steenbruggen, Winnie Schats, Terry Wiersma, Hugo M. Horlings, Ritse Mann, Linetta Koppert, Erik van Werkhoven, Gabe S. Sonke, Agnes Jager Tags: Systematic or Meta-analysis Studies Source Type: research